EUVIMEDEUVIMED entdecken
Crossref

Extracorporeal Immunopharmacotherapy of Autoimmune Diseases

Journal of Clinical & Experimental Immunology · 2019

DOI: 10.33140/jcei.04.01.08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical & Experimental Immunology, 2019.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The article aims to analyze pathogenetic mechanisms of autoimmune diseases development including disorders of both cellular and humoral immunity. The standard drug therapy with corticosteroids and cytostatic leads to a number of side effects such as lipid metabolism disorders (Kushing-syndrome), arterial hypertension, diabetes, and osteoporosis each of which is to be additionally treated. Chimeric monoclonal antibodies (rituximab, natalizumab, etc.) can also cause complications. Therefore apheresis therapy with removal of autoantibodies, circulating immune complexes and other pathological metabolites is pathogenetically justified. However, the greatest effect is reached by means of extracorporeal immunopharmacotherapy when, besides antibodies removal by means of plasmapheresis one performs selection of lymphocytes and their temporary incubation with corticosteroids and cytostatics, which are then returned to the patient. Such targeted immunosuppression is much more effective then “pulse therapy” with minimum negative consequences for the body. At the same time a supporting drug therapy can be carried out with half smaller doses.

Zitieren

APA

(2019). Extracorporeal Immunopharmacotherapy of Autoimmune Diseases. Journal of Clinical & Experimental Immunology. https://doi.org/10.33140/jcei.04.01.08

Vancouver

Extracorporeal Immunopharmacotherapy of Autoimmune Diseases. Journal of Clinical & Experimental Immunology. 2019. doi:10.33140/jcei.04.01.08

BibTeX
@article{euvimed2019,
  title = {Extracorporeal Immunopharmacotherapy of Autoimmune Diseases},
  journal = {Journal of Clinical & Experimental Immunology},
  year = {2019},
  doi = {10.33140/jcei.04.01.08}
}
Kostenlos starten →